ArticleCancer immunology, immunotherapy : CII2020

Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer.

Qilai Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.